These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1455 related articles for article (PubMed ID: 18759926)
21. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease. Chang TT; Kuchroo VK; Sharpe AH Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754 [No Abstract] [Full Text] [Related]
22. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes. Won TJ; Jung YJ; Kwon SJ; Lee YJ; Lee DI; Min H; Park ES; Joo SS; Hwang KW Arch Pharm Res; 2010 Nov; 33(11):1825-33. PubMed ID: 21116786 [TBL] [Abstract][Full Text] [Related]
23. The role of the CD28 receptor during T cell responses to antigen. Linsley PS; Ledbetter JA Annu Rev Immunol; 1993; 11():191-212. PubMed ID: 8386518 [TBL] [Abstract][Full Text] [Related]
24. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. Linsley PS; Bradshaw J; Urnes M; Grosmaire L; Ledbetter JA J Immunol; 1993 Apr; 150(8 Pt 1):3161-9. PubMed ID: 7682233 [TBL] [Abstract][Full Text] [Related]
25. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule. McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604 [TBL] [Abstract][Full Text] [Related]
26. Targeting T cell costimulation in autoimmune disease. Stuart RW; Racke MK Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069 [TBL] [Abstract][Full Text] [Related]
27. PD-1 and its ligands in T-cell immunity. Keir ME; Francisco LM; Sharpe AH Curr Opin Immunol; 2007 Jun; 19(3):309-14. PubMed ID: 17433872 [TBL] [Abstract][Full Text] [Related]
28. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Roy M; Aruffo A; Ledbetter J; Linsley P; Kehry M; Noelle R Eur J Immunol; 1995 Feb; 25(2):596-603. PubMed ID: 7533092 [TBL] [Abstract][Full Text] [Related]
30. Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade. Weber J Semin Oncol; 2010 Oct; 37(5):430-9. PubMed ID: 21074057 [TBL] [Abstract][Full Text] [Related]
31. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. Perrin PJ; Scott D; Quigley L; Albert PS; Feder O; Gray GS; Abe R; June CH; Racke MK J Immunol; 1995 Feb; 154(3):1481-90. PubMed ID: 7529805 [TBL] [Abstract][Full Text] [Related]
32. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623 [TBL] [Abstract][Full Text] [Related]
33. Special regulatory T cell review: The resurgence of the concept of contrasuppression in immunoregulation. Lehner T Immunology; 2008 Jan; 123(1):40-4. PubMed ID: 18154618 [TBL] [Abstract][Full Text] [Related]
34. CTLA-4 and T cell activation. Oosterwegel MA; Greenwald RJ; Mandelbrot DA; Lorsbach RB; Sharpe AH Curr Opin Immunol; 1999 Jun; 11(3):294-300. PubMed ID: 10375557 [TBL] [Abstract][Full Text] [Related]
35. The expanding world of co-stimulation: the two-signal model revisited. Chambers CA Trends Immunol; 2001 Apr; 22(4):217-23. PubMed ID: 11274928 [TBL] [Abstract][Full Text] [Related]
36. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Fife BT; Pauken KE; Eagar TN; Obu T; Wu J; Tang Q; Azuma M; Krummel MF; Bluestone JA Nat Immunol; 2009 Nov; 10(11):1185-92. PubMed ID: 19783989 [TBL] [Abstract][Full Text] [Related]
37. CTLA-4 is required for the induction of high dose oral tolerance. Samoilova EB; Horton JL; Zhang H; Khoury SJ; Weiner HL; Chen Y Int Immunol; 1998 Apr; 10(4):491-8. PubMed ID: 9620605 [TBL] [Abstract][Full Text] [Related]
38. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Chambers CA; Kuhns MS; Egen JG; Allison JP Annu Rev Immunol; 2001; 19():565-94. PubMed ID: 11244047 [TBL] [Abstract][Full Text] [Related]
39. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. Chuang E; Alegre ML; Duckett CS; Noel PJ; Vander Heiden MG; Thompson CB J Immunol; 1997 Jul; 159(1):144-51. PubMed ID: 9200449 [TBL] [Abstract][Full Text] [Related]
40. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family. Bour-Jordan H; Esensten JH; Martinez-Llordella M; Penaranda C; Stumpf M; Bluestone JA Immunol Rev; 2011 May; 241(1):180-205. PubMed ID: 21488898 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]